Physician profile
Phillip Yuan
NPI 1821077595
$59,991.09
in general payments reported to CMS, 2019-2025
42 companies · $18K in 2025
The $18K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $13K · 2021: $2,040 · 2022: $2,106 · 2023: $8,009 · 2024: $5,737 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Food and Beverage: $7,222 · Travel and Lodging: $4,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,600.00 |
| Food and Beverage | $7,222.40 |
| Travel and Lodging | $4,123.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Choice Spine, LLC | $19,617.42 | 2019-2025 | Veo Lateral Interbody Fusion System, Stratofuse, Blackhawk Cervical Spacer System |
| Kuros Biosciences USA, INC | $11,213.97 | 2025 | Magnetos |
| Kyocera Medical Technologies, INC. | $5,247.32 | 2023-2025 | |
| Globus Medical, INC. | $3,942.41 | 2019-2025 | Mars 3v/3vl, Hedron Ia, Alif |
| Medtronic, INC. | $2,574.79 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Inceptiv |
| Nuvasive, INC. | $2,327.20 | 2019-2023 | Alif |
| Depuy Synthes Sales INC. | $2,088.33 | 2019-2025 | Vivigen Mis Delivery System |
| Stryker Corporation | $1,957.04 | 2019-2025 | Aero-Ll, Spinejack, N/A |
| Cerapedics INC. | $1,893.69 | 2019-2025 | I-Factor Peptide Enhanced Bone Graft |
| Bioventus LLC | $1,246.92 | 2020-2025 | Nexus-10 Mkii, Bonescalpel & Sonicone (O.R.), Nexus |
| Prosidyan, INC | $1,000.00 | 2019 | |
| Saxum Surgical, INC. | $992.68 | 2023 | |
| Medtronic USA, INC. | $782.15 | 2019-2020 | |
| Arthrex, INC. | $727.70 | 2023-2024 | Arthrex |
| Si-Bone, INC. | $635.73 | 2019-2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $584.23 | 2019-2021 | |
| Spineart USA INC | $420.50 | 2021-2024 | |
| Nevro Corp. | $380.77 | 2019 | |
| Spineology INC. | $361.61 | 2019-2024 | Optimesh Expandable Interbody Fusion System |
| Ossdsign USA Incorporated | $279.91 | 2025 | Ossdsign Catalyst |
| Boston Scientific Corporation | $244.23 | 2021-2024 | |
| Alphatec Spine, INC | $198.85 | 2020-2024 | Identiti |
| Horizon Therapeutics Plc | $193.36 | 2019 | |
| Providence Medical Technology, INC. | $133.10 | 2021-2025 | |
| Circinus Medical Technology LLC | $133.00 | 2025 | Bolt Navigation |
| Abbott Laboratories | $110.26 | 2019-2025 | Eterna |
| Aesculap Implant Systems, LLC | $107.36 | 2019-2021 | |
| Ethicon US, LLC | $98.30 | 2020 | |
| Osseus Fusion Systems, LLC | $90.00 | 2020 | |
| Xtant Medical INC | $79.15 | 2023-2024 | |
| Biomarin Pharmaceutical INC. | $66.86 | 2020 | |
| Carlsmed, INC. | $59.57 | 2025 | Aprevo |
| Orthofix Medical, INC. | $58.99 | 2025 | Lattus |
| Relievant Medsystems, INC. | $35.82 | 2019 | |
| 4web, INC. | $27.62 | 2025 | Spine Truss System |
| Integrity Implants INC. | $24.59 | 2022 | |
| Merck Sharp & Dohme LLC | $22.88 | 2022 | |
| Nexxt Spine LLC | $17.50 | 2019 | |
| Arteriocyte Medical Systems, INC. | $15.28 | 2022 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Yuan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.